Use of Belatacept as Alternative Immunosuppression in Three Renal Transplant Patients with De Novo Drug-Induced Thrombotic Microangiopathy
Thrombotic microangiopathy (TMA), a severe complication of renal transplantation, is a pathological process involving microvascular occlusion, thrombocytopenia, and microangiopathic hemolytic anemia. It generally appears within the first weeks after transplantation, when immunosuppressive drugs are...
Main Authors: | Federico Cicora, Marta Paz, Fernando Mos, Javier Roberti |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/260254 |
Similar Items
-
Belatacept for Maintenance Immunosuppression in Lung Transplantation
by: Christine Hui PharmD, et al.
Published: (2014-06-01) -
BELATACEPT IN RENAL TRANSPLANTATION
by: A. I. Sushkov, et al.
Published: (2013-03-01) -
Thrombotic microangiopathies postrenal transplantation
by: Kartik Ganesh, et al.
Published: (2020-01-01) -
Streptococcus pneumoniae-associated thrombotic microangiopathy in an immunosuppressed adult
by: Ichikawa Yumi, et al.
Published: (2020-03-01) -
Thrombotic microangiopathy in renal allografts
by: S Radha, et al.
Published: (2014-01-01)